Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA

Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA

Objective. To explore the clinical characteristics of metastatic colorectal cancer combined with gastrointestinal perforation and the prognostic value of circulating tumor DNA (ctDNA). Methods. A total of 97 patients with metastatic colorectal cancer and gastrointestinal perforation were enrolled as...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hong Yang, Dongwen Rong, Wenhui Yang
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2022/6989583
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
by: Jiannan Yao, et al.
Published: (2018-01-01)

Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer
by: Rami Yanes MD, et al.
Published: (2025-01-01)

Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer
by: Der Sheng Sun, et al.
Published: (2017-01-01)

The prognostic value of circulating tumor DNA in malignant melanoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Lei Liu, et al.
Published: (2025-01-01)

Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
by: Susanne Klein‐Scory, et al.
Published: (2025-02-01)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
by: Cheng-Jiang Liu, et al.
Published: (2021-01-01)

Prognostic Value of Metastatic No.8p LNs in Patients with Gastric Cancer
by: Dong-Jiao Guo, et al.
Published: (2015-01-01)

Detection of Circulating Tumor DNA in Patients with Thyroid Nodules
by: Krupal B. Patel, et al.
Published: (2021-01-01)

Metastatic Periampullary Tumor from Hepatocellular Carcinoma Presenting as Gastrointestinal Bleeding
by: Amir Kashani, et al.
Published: (2015-01-01)

Identification of Key Genes and Pathways Involved in Circulating Tumor Cells in Colorectal Cancer
by: Ruijun Pan, et al.
Published: (2022-01-01)

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study
by: François-Clément Bidard, et al.
Published: (2013-01-01)

A Case Report of a Metastatic Gastrointestinal Stromal Tumor Occurring in Femur
by: Chang-kun Zheng, et al.
Published: (2011-01-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
by: Joy A Awosika, et al.
Published: (2024-12-01)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
by: Salman M. Toor, et al.
Published: (2017-01-01)

Prognostic Value of Inflammatory and Nutritional Indicators in Non-Metastatic Soft Tissue Sarcomas
by: Yan Y, et al.
Published: (2025-02-01)

Colorectal Perforation in Patients with Connective Tissue Disease
by: Kiichi Sugimoto, et al.
Published: (2019-01-01)

Combining Serum DNA Methylation Biomarkers and Protein Tumor Markers Improved Clinical Sensitivity for Early Detection of Colorectal Cancer
by: Guoying Zhang, et al.
Published: (2021-01-01)

Gastrointestinal Histoplasmosis Presenting as an Acute Abdomen with Jejunal Perforation
by: Bryan R. Anderson, et al.
Published: (2018-01-01)

The prognostic utility of the ratio of lymphocyte to monocyte in patients with metastatic colorectal cancer: a systematic review and meta-analysis
by: Pingping Mei, et al.
Published: (2025-02-01)

Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
by: Jieun Lee, et al.
Published: (2017-03-01)

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
by: Stacey A. Cohen, et al.
Published: (2022-01-01)

Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain
by: Gard Mikael Sæle Myrmel, MD, et al.
Published: (2025-02-01)

Systematic Therapy for Gastrointestinal Tumors
by: Zhongguang Luo, et al.
Published: (2021-01-01)

Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol
by: Magnús P.B. Obinah, et al.
Published: (2025-02-01)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01)

Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
by: Matthew Burge, et al.
Published: (2023-01-01)

A Profile of Patients on ASA or NSAIDs Hospitalized with Gastrointestinal Perforations
by: James D Bailey, et al.
Published: (1995-01-01)

Perforation of the Jejunum Secondary to AIDS-Related Gastrointestinal Kaposi's Sarcoma
by: Eric M Yoshida, et al.
Published: (1997-01-01)

Tumor Differentiation is the Dominant Prognostic Factor for Patients with Colorectal Neuroendocrine Neoplasms with Distant Metastasis
by: Zhijie Wang, et al.
Published: (2022-01-01)

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
by: Carmine Pinto, et al.
Published: (2025-01-01)

Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
by: Song Dong, PhD, et al.
Published: (2025-01-01)

Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis
by: Xiaoying Tang, et al.
Published: (2025-02-01)

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases
by: Erica S. Tsang, et al.
Published: (2020-01-01)

Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer
by: Anne Meunier, et al.
Published: (2025-02-01)

<i>CYP24A1</i> DNA Methylation in Colorectal Cancer as Potential Prognostic and Predictive Markers
by: Ru-Hua Zhou, et al.
Published: (2025-01-01)

Diagnostic Value of Stool Dna Testing for Multiple Markers Of Colorectal Cancer and Advanced Adenoma: A Meta-Analysis
by: Hua Yang, et al.
Published: (2013-01-01)

Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers
by: Ana Fernández Montes, et al.
Published: (2019-03-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Gastrointestinal stromal tumors
by: A. P. Seryakov
Published: (2010-08-01)